This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Boffa, M.-C. Articles by Lachassinne, E. Search for Related Content PubMed PubMed Citation Articles by Boffa, M.-C. Articles by Lachassinne, E. Social Bookmarking                   What's this?

Review: Infant perinatal thrombosis and antiphospholipid antibodies: a review

Service d'Hématologie, Hopital Jean Verdier, Assistance publique, Hospitaux de Paris, Bondy, France, marieclaire.boffa{at}wanadoo.fr

E. Lachassinne

Service de Pédiatrie, Hôpital Jean Verdier, Assistance publique, Hopitaux de Paris, Bondy, France

Perinatal thrombosis in infants born to mothers with antiphospholipid antibodies (aPL) is a rare event, but with risk of death or severe sequelae. We analysed 16 infants with such perinatal thrombosis reported in the literature in the last 20 years. Thromboses were arterial (13/16), mostly strokes (8/16). Hydrops fetalis with left renal vein thrombosis was associated to a lupus anticoagulant (LA) present only in the child. Risk factors additional to aPL: either prenatal (preeclampsia and/or intra-uterine growth retardation) or perinatal (asphyxia, sepsis, arterial or venous catheter and congenital thrombophilia) were present (one to four of them) in nine out of the 14 evaluable babies. aPL were the only risk factor found in five full term babies who suffered from stroke in four cases and from renal thrombosis in another. Eleven of these infants with aPL in their serum presented a neonatal APS with the same antibody (LA or aCL IgG) found in neonates and their mothers, while the other infants had thrombosis with aPL only in their mother's blood. aCL IgM was only found in one neonate who suffered from sepsis. Thrombosis treatments were diverse. This analysis suggests that women with aPL should be investigated for other thrombophilic risk factors and that aPL should be detected systematically at birth in the offspring of mothers with APS. Lupus (2007) 16 , 634—641.

Key Words: arterial thrombosis • lupus anticoagulant • neonatal antiphospholipid syndrome • stroke • thrombotic risk factor • venous thrombosis

Lupus, Vol. 16, No. 8, 634-641 (2007)
DOI: 10.1177/0961203307079039


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Z Rotar, B Rozman, P. de Groot, M Sanmarco, Y Shoenfeld, P. Meroni, R Cervera, V Pengo, R Cimaz, T Avcin, et al. Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? Lupus, January 1, 2009; 18(1): 53 - 60. [Abstract] [PDF]

				M. J. Simchen, G. Goldstein, A. Lubetsky, T. Strauss, E. Schiff, and G. Kenet Factor V Leiden and Antiphospholipid Antibodies in Either Mothers or Infants Increase the Risk for Perinatal Arterial Ischemic Stroke Stroke, January 1, 2009; 40(1): 65 - 70. [Abstract] [Full Text] [PDF]